The diagnosis and management of children presenting with anaphylaxis to a metropolitan emergency department: A 2-year retrospective case series

• Published in: Journal of paediatrics and child health 2016-05, Vol.52 (5), p.487-492
• Main Authors: Nogic, Claire, Belousoff, Julie, Krieser, David
• Format: Article
• Language: English
• Subjects: Adolescent; allergy; anaphylaxis; Anaphylaxis - diagnosis; Anaphylaxis - drug therapy; Anaphylaxis - physiopathology; Child; Child, Preschool; children; emergency department; Emergency Service, Hospital; Female; Hospitals, Urban; Humans; Male; Retrospective Studies
• ISSN: 1034-4810; 1440-1754
• DOI: 10.1111/jpc.13173

Aim To investigate the diagnosis and management of children with anaphylaxis presenting to an Emergency Department (ED). We compared the management with the Australasian Society of Clinical Immunology and Allergy (ASCIA) guidelines to gauge compliance. Methods A retrospective case series was developed from children aged from birth to 16 years presenting to the ED at Sunshine Hospital (SH) in Melbourne, Australia over a 2‐year period from 1 January 2012 to 31 December 2013. The demographic characteristics, causative agents, clinical features, treatment administered and discharge destination were recorded. Results Fifty‐five children diagnosed with anaphylaxis during the 2‐year period were identified. Fifty‐two children (95%) met the ASCIA diagnostic criteria, 49 (94%) children received adrenaline. The median age of presentation was five years, with males predominating (32 (62%)). The most common setting was home (35 (67%)), and food (39 (75%)) was the most common causative agent. Cutaneous symptoms (50 (96%)) were the most prevalent. Twenty‐eight (54%) children received adrenaline prior to arrival in ED, whilst 22 (42%) received adrenaline in the ED. Thirty‐three (63%) children were discharged home. Conclusion Childhood anaphylaxis commonly presents to the ED. More than half of children presenting with anaphylaxis were treated prior to attending the ED. The findings demonstrate that anaphylaxis diagnosis and management guidelines are being adhered to in the majority of cases. There were no adverse outcomes recorded.